# Task B28: Efficacy Studies for Therapeutics Development

> **NIH NIH N01** · SRI INTERNATIONAL · 2022 · $198,565

## Abstract

This task provides for lead identification, development, chemistry and synthesis services under the NIAID Preclinical Services for the Development of Interventional Agents Program.

## Key facts

- **NIH application ID:** 10703289
- **Project number:** 272201800001I-0-759302200009-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** LEYI GONG
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $198,565
- **Award type:** —
- **Project period:** 2022-09-15 → 2023-03-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703289

## Citation

> US National Institutes of Health, RePORTER application 10703289, Task B28: Efficacy Studies for Therapeutics Development (272201800001I-0-759302200009-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10703289. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*